Search research articles
Contact Us
Filters
Showing results (151-160 of 171) with videos related to
Page
of 18
Sort By:
Virchows Archiv. A, Pathological Anatomy and Histopathology
|
January 1, 1985
Ia+ dendritic cells lining the dermo-epidermal junction in bullous skin disorders, associated with the deposition of immune complexes
M Drijkoningen, C de Wolf-Peeters, J J van den Oord, et al.
International Journal of Dermatology
|
December 1, 1981
Ketoconazole (R 41 400) in the treatment of dermatophyte infections: a clinical, mycological, and morphological study
H Degreef, M Van de Kerckhove, D Gevers, et al.
British Medical Journal
|
November 1, 1980
Oral (E)-5-(2-bromovinyl)-2'-deoxyuridine in severe herpes zoster
E de Clercq, H Degreef, J Wildiers, et al.
Dermatology (Basel, Switzerland)
|
January 1, 1992
A case of Omenn-like immunodeficiency syndrome
M Morren, S Van Lierde, F Lacquet, et al.
The Journal of Pathology
|
July 1, 1984
Usefulness of enzyme-1 and immunohistochemistry in the diagnosis of juvenile xanthogranuloma
C De Wolf-Peeters, F Facchetti, H Degreef, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
April 29, 2005
Case-control study to identify melanoma risk factors in the Belgian population: the significance of clinical examination
T Nijsten, C Leys, K Verbruggen, et al.
Journal of Medical Virology
|
July 27, 2001
A case of human orf in an immunocompromised patient treated successfully with cidofovir cream
K Geerinck, G Lukito, R Snoeck, et al.
Melanoma Research
|
September 14, 2000
Minimal deviation and/or naevoid melanoma: is recognition worthwhile? A clinicopathological study of nine cases
M Stas, J J van den Oord, M Garmyn, et al.
The British Journal of Radiology
|
November 1, 1991
Paget's disease of the male breast treated by radiotherapy
D Verniers, W Van den Bogaert, E van der Schueren, et al.
Journal of the American Academy of Dermatology
|
May 1, 1997
Itraconazole for the treatment of tinea pedis: a dosage of 400 mg/day given for 1 week is similar in efficacy to 100 or 200 mg/day given for 2 to 4 weeks
A K Gupta, P D Doncker, A Heremans, et al.
Page
of 18
Search research articles
Search
Showing results (151-160 of 171) with videos related to
Sort By:
Page
of 18
Virchows Archiv. A, Pathological Anatomy and Histopathology
|
January 1, 1985
Ia+ dendritic cells lining the dermo-epidermal junction in bullous skin disorders, associated with the deposition of immune complexes
M Drijkoningen, C de Wolf-Peeters, J J van den Oord, et al.
International Journal of Dermatology
|
December 1, 1981
Ketoconazole (R 41 400) in the treatment of dermatophyte infections: a clinical, mycological, and morphological study
H Degreef, M Van de Kerckhove, D Gevers, et al.
British Medical Journal
|
November 1, 1980
Oral (E)-5-(2-bromovinyl)-2'-deoxyuridine in severe herpes zoster
E de Clercq, H Degreef, J Wildiers, et al.
Dermatology (Basel, Switzerland)
|
January 1, 1992
A case of Omenn-like immunodeficiency syndrome
M Morren, S Van Lierde, F Lacquet, et al.
The Journal of Pathology
|
July 1, 1984
Usefulness of enzyme-1 and immunohistochemistry in the diagnosis of juvenile xanthogranuloma
C De Wolf-Peeters, F Facchetti, H Degreef, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
April 29, 2005
Case-control study to identify melanoma risk factors in the Belgian population: the significance of clinical examination
T Nijsten, C Leys, K Verbruggen, et al.
Journal of Medical Virology
|
July 27, 2001
A case of human orf in an immunocompromised patient treated successfully with cidofovir cream
K Geerinck, G Lukito, R Snoeck, et al.
Melanoma Research
|
September 14, 2000
Minimal deviation and/or naevoid melanoma: is recognition worthwhile? A clinicopathological study of nine cases
M Stas, J J van den Oord, M Garmyn, et al.
The British Journal of Radiology
|
November 1, 1991
Paget's disease of the male breast treated by radiotherapy
D Verniers, W Van den Bogaert, E van der Schueren, et al.
Journal of the American Academy of Dermatology
|
May 1, 1997
Itraconazole for the treatment of tinea pedis: a dosage of 400 mg/day given for 1 week is similar in efficacy to 100 or 200 mg/day given for 2 to 4 weeks
A K Gupta, P D Doncker, A Heremans, et al.
Page
of 18